CIK 0001808898 · Non-accelerated filer<br>Smaller reporting company
Benitec Biopharma Inc.
Sign in to watch- Ticker
- BNTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- Phone
- (510) 780-0819
- Business address
- 3940 TRUST WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-29 | Oliveira Steven Michael 10% owner | Purchase | +37,947 | $3.18 | $121K | 989,447 |
| 2021-05-03 | Oliveira Steven Michael 10% owner | Purchase | +40,500 | $4.25 | $172K | 951,500 |
| 2021-04-30 | Oliveira Steven Michael 10% owner | Purchase | +120,000 | $4.18 | $502K | 911,000 |
| 2021-04-29 | Oliveira Steven Michael 10% owner | Purchase | +22,877 | $5.49 | $126K | 791,000 |
| 2021-04-28 | Oliveira Steven Michael 10% owner | Purchase | +100,000 | $5.45 | $545K | 768,123 |
| 2020-12-09 | BUCHI J KEVIN Director | Grant or award · Options (right to buy) | +23,601 | 23,601 | ||
| 2020-12-09 | Francis Peter Director | Grant or award · Options (right to buy) | +23,601 | 23,601 | ||
| 2020-12-09 | Smith Edward F Director | Grant or award · Options (right to buy) | +23,601 | 23,601 | ||
| 2020-12-09 | Boston Megan Executive Director | Grant or award · Options (right to buy) | +142,172 | 142,172 | ||
| 2020-12-09 | Banks Jerel A. Chief Executive Officer | Grant or award · Options (right to buy) | +284,345 | 284,345 |
Page 5 of 5 · 90 trades